Announcements
1 July 2024
Neurology International Receives an Updated Impact Factor of 3.2 and CiteScore of 3.7
We are pleased to share that Neurology International (ISSN: 2035-8377) was awarded an increased impact factor of 3.2 in the 2023 Journal Citation Reports™ released by Clarivate in June 2024. Neurology International ranks Q2 (80 among 277 titles) in the “Clinical Neurology” category.
Additionally, according to data released by Scopus (Elsevier), Neurology International received an increased CiteScore™ of 3.7, an increase of 68.2% compared with the 2021 metric.
Neurology International ranks 208 among 400 titles (Q3) in the “Neurology (clinical)” category.
|
3.22023 Impact Factor |
80/277 (Q2)Clinical Neurology |
474Citations in 2023 |
|
3.72023 CiteScore |
208/400 (Q3)Neurology (clinical) |
1.080SNIP |
For further statistics, please visit https://www.mdpi.com/journal/neurolint/stats. For more information about MDPI flagship journals’ citation metrics, please see here.
At MDPI, our mission is simple yet powerful, and we strive every day to make scientific research freely accessible to everyone, everywhere. With over 3.5 million authors choosing MDPI, we have established ourselves as a key player driving the open access initiative.
Our journals have received over 13 million citations in Web of Science, making us the most cited open access publisher. With over 800 institutional partners, MDPI continues to demonstrate its dedication to providing reliable and collaborative publishing services.
Neurology International Editorial Office
